| Returns | 1W : -2.9% , 1M : -2.9%,1Y : -12.9% | www.aurobindo.com |
| LT : |
Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued] Debt : Average |
| ST : |
Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : None or < 25% |
| Peers & Returns | 1W | 1M | 1Y |
| AUROBINDO PHARMA | -2.9% | -2.9% | -12.9% |
| SUN PHARMACEUTICAL INDUSTRIES | -2.8% | 7% | 67.4% |
| DIVIS LABORATORIES | -3.4% | 0.2% | 58.9% |
| DR REDDYS LABORATORIES | -6.3% | -4.3% | -6.4% |
| CIPLA | -0% | -4.7% | 15.7% |
| GLAND PHARMA | -4.3% | -6.3% | NA |
| PIRAMAL ENTERPRISES | -5.4% | 2.7% | 106.2% |
| CADILA HEALTHCARE | -6.3% | -7.3% | 20.1% |
| TORRENT PHARMACEUTICALS | -3.9% | -1.2% | 8.6% |
| Ratio | Consolidated |
|---|---|
|
P/E P/B P/S |
7.75
P/E Calculated based on EPS of 91.05
[ Mar2021 - Consolidated Results ] 1.88
P/B Calculated based on Book Value of 374.29
[ Mar2021 - Consolidated Results ] 1.68
P/S Calculated based on Revenues of 24551.8 Cr
[ TTM - Consolidated Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
-19% -21% -3% |
| Pledged Shares |
22.98 % |
|---|---|
| As on : Sep2021 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE LARGECAP | -1.2% | 3.5% | 56.9% |
| S&P BSE ENHANCED VALUE | -1.2% | 12.2% | 131% |
| S&P BSE 100 LARGECAP TMC | -1.2% | 3.3% | 57.6% |
| S&P BSE CARBONEX | -1.3% | 3.9% | 58% |
| S&P BSE 100 | -1.3% | 3.4% | 57.9% |
| S&P BSE LARGE MIDCAP | -1.5% | 3.6% | 59.8% |
| S&P BSE 200 | -1.5% | 3.6% | 60.9% |
| S&P BSE 250 LARGEMIDCAP | -1.6% | 3.6% | 61.4% |
| S&P BSE 500 | -1.8% | 3.7% | 63.3% |
| S&P BSE ALLCAP | -1.9% | 3.7% | 64.4% |
| S&P BSE DIVIDEND STABILITY | -2.6% | 8.4% | 67% |
| S&P BSE HEALTHCARE | -3.7% | -3.1% | 29.7% |
| S&P BSE SENSEX NEXT 50 | -3.8% | 2.8% | 67.8% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY LARGE MIDCAP 250 | -1.1% | 5.6% | 70% |
| NIFTY500 MULTICAP 50:25:25 | -1.2% | 5.4% | NA |
| NIFTY 100 | -1.3% | 3.1% | 57.1% |
| NIFTY 200 | -1.6% | 3.6% | 60.7% |
| NIFTY 500 | -1.8% | 3.6% | 63% |
| NIFTY 100 EQUAL WEIGHT | -2.4% | 2.6% | 68.9% |
| NIFTY GROWTH SECTOR 15 | -2.9% | -0.4% | 42.8% |
| NSE QUALITY 30 | -3.1% | -1.3% | 46.2% |
| NIFTY HEALTHCARE | -3.4% | -2% | NA |
| NIFTY NEXT 50 | -3.6% | 0.7% | 60.9% |
| NIFTY PHARMA | -3.8% | -0.8% | 21.8% |
#15A, 4th Floor, City Vista, Tower A,
Suite No.984, Fountain Road,
Kharadi, Pune - 411014
Contact Us
support@smart-investing.in
Smart-Investing.in
Pricing
Video Course
Blog
Tools
Screener
Compare
Analyze Portfolio
© 2019 - 2021 Smart-Investing.in. All rights reserved. Built with ❤️ in India
Disclaimer
The information on this site is for educational purposes only and is not investment/trading advice/research and may be delayed.
We don't make any Buy/Sell recommendations and don't give any price targets.
This tool provides statistical summaries of financial data in easy to understand visual form for informational purpose only.
Please do your own research before making any investment decisions.
Equity investments are volatile and high risk in nature. Don't invest more than what you can afford to lose. Past Performance is not indicative of future returns.
We have affiliate relationships with Amazon and Zerodha.
Financial Data Source: Accord Fintech |
Methodology |
Privacy Policy |
Terms & Conditions |
SEBI Registered Research Analyst Registration No : INH000007377 |
Disclosure